Form 4: IQVIA Executive Keriann Cherofsky Reports Stock Transactions
SEC Form 4 Filing
Keriann Cherofsky, an executive at IQVIA Holdings Inc., reported the acquisition of common stock and stock appreciation rights, along with the disposition of shares to cover tax obligations.
Summary
- Keriann Cherofsky, a Senior Vice President at IQVIA Holdings Inc., reported several transactions involving the company's stock on January 28, 2025.
- These transactions include the acquisition of 441 shares of common stock related to performance-based restricted stock units granted in 2022.
- Additionally, 2,457 restricted stock units were granted, which will vest fully on the third anniversary of the grant date.
- A total of 176 shares were disposed of at a price of $203.43 per share to cover tax obligations.
- Cherofsky also acquired 2,633 stock appreciation rights, which vest in three annual installments starting January 28, 2026.
Sentiment
Score: 7
Explanation: The document reflects standard executive compensation practices and does not indicate any significant positive or negative events. The vesting of performance-based awards suggests the company is meeting its goals, which is a positive sign.
Positives
- The vesting of performance-based restricted stock units indicates that the company met certain performance goals.
- The grant of additional restricted stock units suggests continued confidence in the company's future performance.
- The acquisition of stock appreciation rights provides an incentive for future growth.
Negatives
- The disposition of 176 shares to cover tax obligations resulted in a reduction of Cherofsky's direct holdings.
Future Outlook
The restricted stock units granted will vest on the third anniversary of the grant date, and the stock appreciation rights will vest in three annual installments starting January 28, 2026.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common practice in publicly traded companies. It provides transparency into the compensation and ownership structure of the company's leadership.
Comparison to Industry Standards
- Stock-based compensation, including restricted stock units and stock appreciation rights, is a common practice among publicly traded companies, particularly in the technology and healthcare sectors, to align executive interests with shareholder value.
- Companies like Oracle, Accenture, and Cognizant, which are in similar industries to IQVIA, also use similar compensation methods.
- The vesting schedules and performance criteria are generally in line with industry standards for executive compensation.
Stakeholder Impact
- The transactions have a minor positive impact on shareholders as they indicate that the company is meeting performance goals and incentivizing executives.
- The transactions have a minor impact on the executive, as they are receiving stock-based compensation.
Key Dates
| Date | Description |
|---|---|
| 02/10/2022 | Date of initial grant of performance-based restricted stock units. |
| 07/28/2022 | Date of additional grant of performance-based restricted stock units. |
| 01/28/2025 | Date of reported transactions, including vesting of performance-based restricted stock units, grant of new restricted stock units, disposition of shares for tax obligations, and grant of stock appreciation rights. |
| 01/28/2026 | Start date for the vesting of stock appreciation rights in three annual installments. |
| 01/28/2035 | Expiration date of the stock appreciation rights. |
Keywords
IQVIA, stock transactions, Form 4, restricted stock units, stock appreciation rights, executive compensation, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.